UY29124A1 - Compuestos de quinolina - Google Patents

Compuestos de quinolina

Info

Publication number
UY29124A1
UY29124A1 UY29124A UY29124A UY29124A1 UY 29124 A1 UY29124 A1 UY 29124A1 UY 29124 A UY29124 A UY 29124A UY 29124 A UY29124 A UY 29124A UY 29124 A1 UY29124 A1 UY 29124A1
Authority
UY
Uruguay
Prior art keywords
compounds
levels
certain
triglycerides
quinoline compounds
Prior art date
Application number
UY29124A
Other languages
English (en)
Inventor
Roger Benjamin Ruggeri
David Austen Perry
Mary Theresa Didiuk
Ryan Michael Kelley
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY29124A1 publication Critical patent/UY29124A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Compuestos de quinolina, composiciones farmacéuticas que contienen tales compuestos y el uso de tales compuestos para elevar ciertos niveles de lípidos en plasma, incluyendo el colessterol asociado a lipoproteínas de alta densidad y para reducir otros ciertos niveles de lípidos en plasma, tales como el colesterol LDL y los triglicéridos y, por consiguiente, para tratar enfermedades que están exacerbadas por bajos niveles de colesterol HDL y/o altos niveles de colesterol LDL y triglicéridos, tales como la aterosclerosis y enfermedades cardiovasculares en ciertos mamíferos incluyendo los seres humanos.
UY29124A 2004-09-23 2005-09-20 Compuestos de quinolina UY29124A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61286304P 2004-09-23 2004-09-23

Publications (1)

Publication Number Publication Date
UY29124A1 true UY29124A1 (es) 2006-04-28

Family

ID=35511128

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29124A UY29124A1 (es) 2004-09-23 2005-09-20 Compuestos de quinolina

Country Status (8)

Country Link
US (1) US20070149567A1 (es)
AR (1) AR054085A1 (es)
GT (1) GT200500264A (es)
NL (1) NL1030012C2 (es)
PE (1) PE20060819A1 (es)
TW (1) TW200616964A (es)
UY (1) UY29124A1 (es)
WO (1) WO2006033004A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003269327A1 (en) * 2002-10-21 2004-05-04 Warner-Lambert Company Llc Tetrahydroquinoline derivatives as crth2 antagonists
PT1740591E (pt) 2004-04-02 2009-09-24 Osi Pharm Inc Inibidores da proteína quinase heterobicíclicos em substituição de anel bicíclico 6,6
WO2007107843A1 (en) * 2006-03-22 2007-09-27 Pfizer Products Inc. Methods of treatment with cetp inhibitors
JP2012524119A (ja) 2009-04-20 2012-10-11 オーエスアイ・ファーマシューティカルズ，エルエルシー Ｃ−ピラジン−メチルアミンの調製
CA2809958A1 (en) 2010-08-31 2012-03-08 Snu R & Db Foundation Use of the fetal reprogramming of a ppar ? agonist

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT199900147A (es) * 1998-09-17 1999-09-06 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
CO5271716A1 (es) * 1999-11-30 2003-04-30 Pfizer Prod Inc Cristales de 4- carboxamino 1,2,3,4-tetrahidroquinolina 2- sustituida
MXPA05010456A (es) * 2003-03-28 2006-03-21 Pfizer Prod Inc Compuestos de quinolina y quinoxalina.
MXPA06003499A (es) * 2003-09-30 2006-06-08 Pfizer Prod Inc Inhibidores de proteina de transferencia de esteres de colestrerilo y sus metabolitos.

Also Published As

Publication number Publication date
AR054085A1 (es) 2007-06-06
PE20060819A1 (es) 2006-09-02
NL1030012C2 (nl) 2006-11-21
US20070149567A1 (en) 2007-06-28
GT200500264A (es) 2006-06-02
TW200616964A (en) 2006-06-01
NL1030012A1 (nl) 2006-03-27
WO2006033004A1 (en) 2006-03-30

Similar Documents

Publication Publication Date Title
UY29222A1 (es) Compuestos y derivados de dibencil amina
CR10265A (es) Compuestos y derivados de dibencilamina.
UY28243A1 (es) Compuestos de quinolina y qunoxalina
SV2003000886A (es) Agonistas de ppar ref. pc11023aado/bb
UY28097A1 (es) Activadores de ppar
CR9012A (es) Compuestos de 4-amino-sustituido-2-sustituido-1,2,3,4-tetrahidroquinolina
PA8539101A1 (es) Compuestos de ppar
UY29124A1 (es) Compuestos de quinolina
ECSP088729A (es) Compuestos y derivados de dibencilamina
BRPI0607839A2 (pt) compostos 1,1,1-triflúor-3-[(benzil)-(pirimidin-2-il)-amino]-propan- 2-ol substituìdos
DOP2005000179A (es) Compuesto de quinolina
DOP2002000327A (es) Agonistas de ppar
CU20080164A7 (es) Compuestos y derivados de dibencilamina
UY27168A1 (es) Agonistas de ppar
ECSP088730A (es) Derivados de dibencilamina como inhibidores de cetp
DOP2005000238A (es) Compuestos y derivados de dibencil amina
UY27158A1 (es) Compuestos de ppar
DOP2004000863A (es) Compuestos de quinolina y quinoxalina
DOP2002000331A (es) Compuesto de ppar
DOP2003000762A (es) Activadores de ppar
UY29123A1 (es) Compuestos de 4-amino-sustituido-2-sustituido-1,2,3,4-tetrahidroquinolina
SV2006002314A (es) Compuestos y derivados de dibencil amina ref. no. pc32592a
DOP2005000182A (es) Compuestos de 4-amino-sustituido-2-sustituido-1,2,3-tetrahidroquinolina
PA8589501A1 (es) Activadores de ppar
ECSP993135A (es) 1,2,3,4- tetrahidroquinolinas -2 -sustituidas 4- amino sustituidas

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160530